Submitted by Anonymous on Thu, 26/05/2011 - 19:55.
If any company is stupid enough to buy two Celigo's then the pharma industry is worse shape than I thought.
The only sales reps posting are those saying Celigo is selling. Most units are being given away on the promise of software that works.
I heard get a LEAP half price and a Celigo thrown in for free ...
Submitted by Anonymous on Tue, 24/05/2011 - 19:43.
The Celigo total crap. Not scientific at all! Completely subjective data, basically you can adjust your analysis of each plate so it fits what you want it to look like. Picks up empty space as a cell if you want to have more numbers for proliferation, ignore cells in your count if you want it to. Every other day the scan does not work. I refuse to work on this machine, ever!
Submitted by Anonymous on Fri, 10/12/2010 - 13:15.
Thank you for the comments about the company, any substantive comments about the box?
Yes the box is crap ! The software is awful and cannot analyse the most simple fluorescence application, brightfield imaging does not work on cells in plates - too much random light. When we had a demo the sales reps standard features was "that is under development and will be available shortly". I am still waiting 6 months laster and have bought an alternative in the meantime.
This box has a poor outlook in my opinion and if any of the comments below are true then future support may be non-existent.
Submitted by Anonymous on Thu, 02/09/2010 - 11:48.
Celigo box is crash 'n' burning all over Europe. Crap software, low functionality, wrong excitation ...
Looks like a salesforce just going through the motions to get the month-end cheque.
I'll give them 2 months ...
Submitted by Anonymous on Mon, 24/05/2010 - 10:11.
5/21/2010
San Diego-based Cyntellect, a provider of biotech research instruments, has raised $9 million in equity, debt, and rights funding, according to an SEC filing. The company told VentureWire that the funding added to its Series E round, in which the firm raised $16 million last year, from undisclosed investors. Cyntellect’s instruments are designed to analyze, purify, and grow cells for life sciences research, according to product overviews on its website. In March, the company said it would provide its microplate-based cytometry system to scientists from Harvard University and the Howard Hughes Medical Institute for stem cell research.
Submitted by Anonymous on Sun, 23/05/2010 - 13:21.
The company is a wreck. They've reshuffled the executive management, fired most of the sales team (US and EU), and decimated the marketing group. Looks like the spent way too much money early in the life-cycle and are now strapped. They will most certainly be acquired, soon.
Please do your instrument
Please do your instrument development in house and not on The Mill !!
And preferably do it before releasing a product ...
Sluggo
I would like to know how the
I would like to know how the software doesn't work?
If any company is stupid
If any company is stupid enough to buy two Celigo's then the pharma industry is worse shape than I thought.
The only sales reps posting are those saying Celigo is selling. Most units are being given away on the promise of software that works.
I heard get a LEAP half price and a Celigo thrown in for free ...
spoken like a true sales
spoken like a true sales rep>>>who do you work for? Total crap-thats why pharma co. just bought there second one.
The Celigo total crap. Not
The Celigo total crap. Not scientific at all! Completely subjective data, basically you can adjust your analysis of each plate so it fits what you want it to look like. Picks up empty space as a cell if you want to have more numbers for proliferation, ignore cells in your count if you want it to. Every other day the scan does not work. I refuse to work on this machine, ever!
A bad execution on a half
A bad execution on a half baked idea, or is it the other way around?
Cyntellect were not at HCA
Cyntellect were not at HCA 2011 - no stand, no poster.
Start contrast to their sponsorship of the event last year ...
Thank you for the comments
Thank you for the comments about the company, any substantive comments about the box?
Yes the box is crap ! The software is awful and cannot analyse the most simple fluorescence application, brightfield imaging does not work on cells in plates - too much random light. When we had a demo the sales reps standard features was "that is under development and will be available shortly". I am still waiting 6 months laster and have bought an alternative in the meantime.
This box has a poor outlook in my opinion and if any of the comments below are true then future support may be non-existent.
One man band in Europe
One man band in Europe
Thank you for the comments
Thank you for the comments about the company, any substantive comments about the box?
I've heard that Gacy at
I've heard that Gacy at Ebioscience might be making an instrument play. But Cyntellect would not be "it" - no matter how low the price.....
Cyntellect is circling the drain...
They needed to make a lot of
They needed to make a lot of progress on both fronts as the software was third world. I hear you can get a Celigo given to you if you ask nicely :0)
Anyone who has a Celigo box
Anyone who has a Celigo box care to comment? Heard they have made some progress on brightfield imaging and analysis.
This company was toast from
This company was toast from day one. When I visited them they really did not understand the cellular market.
More leavers in Europe - rats
More leavers in Europe - rats leaving the sinking ship
Celigo box is crash 'n'
Celigo box is crash 'n' burning all over Europe. Crap software, low functionality, wrong excitation ...
Looks like a salesforce just going through the motions to get the month-end cheque.
I'll give them 2 months ...
New CEO same duff products
New CEO same duff products ...
CYNTELLECT APPOINTS SAIID ZARRABIAN AS CEO
Wow at this burn rate they
Wow at this burn rate they will be history in 6 months !!
Still not sure if they see LEAP (cell purifier) or Celigo (cell imager) as their saviour ...
5/21/2010 San Diego-based
5/21/2010
San Diego-based Cyntellect, a provider of biotech research instruments, has raised $9 million in equity, debt, and rights funding, according to an SEC filing. The company told VentureWire that the funding added to its Series E round, in which the firm raised $16 million last year, from undisclosed investors. Cyntellect’s instruments are designed to analyze, purify, and grow cells for life sciences research, according to product overviews on its website. In March, the company said it would provide its microplate-based cytometry system to scientists from Harvard University and the Howard Hughes Medical Institute for stem cell research.
So in that case it will be
So in that case it will be cheap then LOL!!!
What is there to acquire? One
What is there to acquire?
One product: One Market: No Sales !!
Could be GE, I hear that they
Could be GE, I hear that they are looking for small companies to buy at the moment as there LS business is going backwards
The company is a wreck.
The company is a wreck. They've reshuffled the executive management, fired most of the sales team (US and EU), and decimated the marketing group. Looks like the spent way too much money early in the life-cycle and are now strapped. They will most certainly be acquired, soon.
Yep most of Europe gone!
Yep most of Europe gone!
Put your money on Millipore,
Put your money on Millipore, soon to be EMD-Millipore, buying them!
Yeah - but who can afford
Yeah - but who can afford it?? Nice toy, but can't see many justifying the cost.
Doesn't quite add up with the
Doesn't quite add up with the glitzy launch of their new instrument
Post new comment